Cargando…

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?

Detalles Bibliográficos
Autores principales:	Godoy, Lucas C, Farkouh, Michael E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2019
Materias:	Cardiovascular Pharmacotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950347/ https://www.ncbi.nlm.nih.gov/pubmed/31933688 http://dx.doi.org/10.15420/ecr.2019.14.3.GE1

Ejemplares similares

Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?
por: Battistoni, Allegra, et al.
Publicado: (2020)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Lomakin, Nikita, et al.
Publicado: (2019)

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
por: Shimizu, Kana, et al.
Publicado: (2019)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations
por: Sorathia, Nilofer, et al.
Publicado: (2019)

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
por: Barnes, Neil, et al.
Publicado: (2013)

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
por: Raphael, Gordon, et al.
Publicado: (2016)

Early Australian experience in the maintenance of schizophrenia management with 3-monthly paliperidone palmitate
por: Pai, Nagesh, et al.
Publicado: (2018)

Endothelial Dysfunction in Patients With Erectile Dysfunction: A Double-Blind, Randomized-Control Trial Using Tadalafil
por: Pattanaik, Smita, et al.
Publicado: (2019)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019)

AF in Cancer Patients: A Different Need for Anticoagulation?
por: Sanz, Ana Pardo, et al.
Publicado: (2019)

Safety and Tolerability of Evening Ethanol Consumption and Bedtime Administration of Flibanserin in Healthy Premenopausal Female Subjects
por: Millheiser, Leah, et al.
Publicado: (2019)

Testosterone Management in Aging Males: Surveying Clinical Practices of Urologists and Endocrinologists in Israel
por: Ishay, Avraham, et al.
Publicado: (2019)

Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
por: Camarero, Tamara García, et al.
Publicado: (2020)

Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Lugo, Leslie Marisol, et al.
Publicado: (2020)

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020)

The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study
por: Gallo, Luigi, et al.
Publicado: (2020)

Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction
por: Zhang, Jian, et al.
Publicado: (2020)

The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects
por: Gerritsen, Jeroen, et al.
Publicado: (2020)

A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
por: Ahmad, Tariq, et al.
Publicado: (2021)

D-53 | Impact of Cardiovascular Diseases, Calcium Channel Blockers and Beta-Blockers on Mortality of Patients Hospitalized with COVID-19
por: Alhusain, Rashid, et al.
Publicado: (2022)

Effect of the new 75-mg orodispersible film of sildenafil on erection and sexual quality of life: insights from an observational study
por: Sansone, Andrea, et al.
Publicado: (2023)

Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023)

STOMp: sexual function trial of overactive bladder medication
por: Polland, Allison, et al.
Publicado: (2023)

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility
por: Borgert, Benjamin J, et al.
Publicado: (2023)

Perspectives and Future Directions of Anticoagulant Therapy in Coronary Artery Disease Patients
por: Komiyama, Maki, et al.
Publicado: (2023)

Nuclear Factor-κB is a Prime Candidate for the Diagnosis and Control of Inflammatory Cardiovascular Disease
por: Matsumori, Akira
Publicado: (2023)

Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction
por: Kilic, Metin, et al.
Publicado: (2023)

Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel
por: Tan, Cheng Keat, et al.
Publicado: (2023)

Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis
por: Shin, Young Eun, et al.
Publicado: (2023)

The Risk of Thrombosis Around Pregnancy: Where Do We Stand?
por: Gris, Jean-Christophe, et al.
Publicado: (2022)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Savarese, Gianluigi
Publicado: (2019)

Detection of myocardial fibrosis: Where we stand
por: Zhu, Leyi, et al.
Publicado: (2022)

Where Do We Stand?
Publicado: (1891)

Platelet Rich Plasma in Androgenic Alopecia: Where do we Stand?
por: Godse, Kiran
Publicado: (2014)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
por: Manto, Mario, et al.
Publicado: (2018)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lq3vf8tb3pjsap0ehpip5djrru